Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
EditorialEditorial

Does Viral Hemorrhagic Fever Represent Reactive Hemophagocytic Syndrome?

RANDY Q. CRON, EDWARD M. BEHRENS, BITA SHAKOORY, ATHIMALAIPET V. RAMANAN and WALTER W. CHATHAM
The Journal of Rheumatology July 2015, 42 (7) 1078-1080; DOI: https://doi.org/10.3899/jrheum.150108
RANDY Q. CRON
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama;
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rcron@peds.uab.edu
EDWARD M. BEHRENS
Department of Pediatrics, University of Pennsylvania;
Roles: Assistant Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BITA SHAKOORY
Department of Medicine, Temple University, Philadelphia, Pennsylvania, USA;
Roles: Assistant Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ATHIMALAIPET V. RAMANAN
Department of Paediatrics, Bristol Royal Hospital for Children, Bristol, UK;
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WALTER W. CHATHAM
Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Roles: Professor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Kalra S,
    2. Kelkar D,
    3. Galwankar SC,
    4. Papadimos TJ,
    5. Stawicki SP,
    6. Arquilla B,
    7. et al.
    The emergence of ebola as a global health security threat: from ‘lessons learned’ to coordinated multilateral containment efforts. J Glob Infect Dis 2014;6:164–77.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Cohen J
    . Saving lives without new drugs. Science 2014;346:911.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Peacock G,
    2. Uyeki TM,
    3. Rasmussen SA
    . Ebola virus disease and children: what pediatric health care professionals need to know. JAMA Pediatr 2014;168:1087–8.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. McElroy AK,
    2. Erickson BR,
    3. Flietstra TD,
    4. Rollin PE,
    5. Nichol ST,
    6. Towner JS,
    7. et al.
    Ebola hemorrhagic fever: novel biomarker correlates of clinical outcome. J Infect Dis 2014;210:558–66.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Minoia F,
    2. Davi S,
    3. Horne A,
    4. Demirkaya E,
    5. Bovis F,
    6. Li C,
    7. et al.
    Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheumatol 2014;66:3160–9.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Chatham WW,
    2. Cron RQ
    . Ebola: hemorrhagic fever and macrophage activation syndrome. The Rheumatologist 2014;8:1,21–23. [Internet. Accessed May 6, 2015.] Available from: www.the-rheumatologist.org/details/article/7131051/Ebola_Hemorrhagic_Fever_and_Macrophage_Activation_Syndrome.html
    OpenUrl
  7. 7.↵
    1. Bakir M,
    2. Ugurlu M,
    3. Dokuzoguz B,
    4. Bodur H,
    5. Tasyaran MA,
    6. Vahaboglu H
    . Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005;54:385–9.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Rathakrishnan A,
    2. Klekamp B,
    3. Wang SM,
    4. Komarasamy TV,
    5. Natkunam SK,
    6. Sathar J,
    7. et al.
    Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia. PLoS One 2014;9:e92021.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Bicakci Z,
    2. Tavil B,
    3. Tezer H,
    4. Olcay L
    . Hemophagocytosis in a case with Crimean-Congo hemorrhagic fever and an overview of possible pathogenesis with current evidence. Turk J Pediatr 2013;55:344–8.
    OpenUrlPubMed
  10. 10.↵
    1. Tan LH,
    2. Lum LC,
    3. Omar SF,
    4. Kan FK
    . Hemophagocytosis in dengue: comprehensive report of six cases. J Clin Virol 201255:79–82.
  11. 11.↵
    1. Chaiyaratana W,
    2. Chuansumrit A,
    3. Atamasirikul K,
    4. Tangnararatchakit K
    . Serum ferritin levels in children with dengue infection. Southeast Asian J Trop Med Public Health 2008;39:832–6.
    OpenUrlPubMed
  12. 12.↵
    1. Ravelli A,
    2. Grom AA,
    3. Behrens EM,
    4. Cron RQ
    . Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun 2012;13:289–98.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Zhang M,
    2. Behrens EM,
    3. Atkinson TP,
    4. Shakoory B,
    5. Grom AA,
    6. Cron RQ
    . Genetic defects in cytolysis in macrophage activation syndrome. Curr Rheumatol Rep 2014;16:439–46.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Jordan MB,
    2. Hildeman D,
    3. Kappler J,
    4. Marrack P
    . An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 2004;104:735–43.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Sepulveda FE,
    2. Maschalidi S,
    3. Vosshenrich CA,
    4. Garrigue A,
    5. Kurowska M,
    6. Menasche G,
    7. et al.
    A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice. Blood 2015;125:1427–34.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Behrens EM,
    2. Canna SW,
    3. Slade K,
    4. Rao S,
    5. Kreiger PA,
    6. Paessler M,
    7. et al.
    Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J Clin Invest 2011;121:2264–77.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Maude SL,
    2. Frey N,
    3. Shaw PA,
    4. Aplenc R,
    5. Barrett DM,
    6. Bunin NJ,
    7. et al.
    Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med 2014;371:1507–17.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Angus DC,
    2. van der Poll T
    . Severe sepsis and septic shock. N Engl J Med 2013;369:840–51.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Raju S,
    2. Kalyanaraman S,
    3. Swaminathan K,
    4. Nisha A,
    5. Praisid S
    . Hemophagocytic lymphohistiocytosis syndrome in dengue hemorrhagic fever. Indian J Pediatr 2014;81:1381–3.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Ramachandran B,
    2. Balasubramanian S,
    3. Abhishek N,
    4. Ravikumar KG,
    5. Ramanan AV
    . Profile of hemophagocytic lymphohistiocytosis in children in a tertiary care hospital in India. Indian Pediatr 2011;48:31–5.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Erduran E,
    2. Bahadir A,
    3. Palanci N,
    4. Gedik Y
    . The treatment of crimean-congo hemorrhagic fever with high-dose methylprednisolone, intravenous immunoglobulin, and fresh frozen plasma. J Pediatr Hematol Oncol 2013;35:e19–24.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Zhang AP,
    2. Bornholdt ZA,
    3. Liu T,
    4. Abelson DM,
    5. Lee DE,
    6. Li S,
    7. et al.
    The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold. PLoS Pathog 2012;8:e1002550.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Wauquier N,
    2. Becquart P,
    3. Padilla C,
    4. Baize S,
    5. Leroy EM
    . Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 2010;4:pii:e837.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Leroy EM,
    2. Baize S,
    3. Volchkov VE,
    4. Fisher-Hoch SP,
    5. Georges-Courbot MC,
    6. Lansoud-Soukate J,
    7. et al.
    Human asymptomatic Ebola infection and strong inflammatory response. Lancet 2000;355:2210–5.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Baize S,
    2. Leroy EM,
    3. Georges AJ,
    4. Georges-Courbot MC,
    5. Capron M,
    6. Bedjabaga I,
    7. et al.
    Inflammatory responses in Ebola virus-infected patients. Clin Exp Immunol 2002;128:163–8.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. van der Ven AJ,
    2. Netea MG,
    3. van der Meer JW,
    4. de Mast Q
    . Ebola virus disease has features of hemophagocytic lymphohistiocytosis syndrome. Front Med 2015;2:4.
    OpenUrl
  27. 27.↵
    1. Opal SM,
    2. Fisher CJ Jr,
    3. Dhainaut JF,
    4. Vincent JL,
    5. Brase R,
    6. Lowry SF,
    7. et al.
    Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. Crit Care Med 1997;25:1115–24.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Miettunen PM,
    2. Narendran A,
    3. Jayanthan A,
    4. Behrens EM,
    5. Cron RQ
    . Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology 2011;50:417–9.
    OpenUrlFREE Full Text
  29. 29.↵
    1. Ishii E,
    2. Ohga S,
    3. Imashuku S,
    4. Yasukawa M,
    5. Tsuda H,
    6. Miura I,
    7. et al.
    Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007;86:58–65.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Vanden Berghe T,
    2. Demon D,
    3. Bogaert P,
    4. Vandendriessche B,
    5. Goethals A,
    6. Depuydt B,
    7. et al.
    Simultaneous targeting of IL-1 and IL-18 is required for protection against inflammatory and septic shock. Am J Respir Crit Care Med 2014;189:282–91.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 7
1 Jul 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Does Viral Hemorrhagic Fever Represent Reactive Hemophagocytic Syndrome?
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Does Viral Hemorrhagic Fever Represent Reactive Hemophagocytic Syndrome?
RANDY Q. CRON, EDWARD M. BEHRENS, BITA SHAKOORY, ATHIMALAIPET V. RAMANAN, WALTER W. CHATHAM
The Journal of Rheumatology Jul 2015, 42 (7) 1078-1080; DOI: 10.3899/jrheum.150108

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Does Viral Hemorrhagic Fever Represent Reactive Hemophagocytic Syndrome?
RANDY Q. CRON, EDWARD M. BEHRENS, BITA SHAKOORY, ATHIMALAIPET V. RAMANAN, WALTER W. CHATHAM
The Journal of Rheumatology Jul 2015, 42 (7) 1078-1080; DOI: 10.3899/jrheum.150108
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Clinical Features of Viral Hemorrhagic Fever (VHF)
    • Pathophysiology of Hemophagocytic Syndromes
    • Implications for Treatment of VHF as rHPS
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Beyond Empowerment in Rheumatology Care
  • The Use of Mobile Health Apps in Clinical Practice Remains Challenging
  • Taking the Long View: Patients Perceive Benefits and Risks of Treatment as Multidimensional
Show more Editorial

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire